From all of us at OMAPiX!
Info
We do not understand biology enough. Although we have made significant progress in understanding how the biological systems function, we still lack the understanding of how, when, and importantly where key biological events take place and how those events go awry during disease. It is not a hidden fact that we still do not have cures for devastating diseases such as cancer, Alzheimer's, or Parkinson's disease. We need to understand biology at three levels with the highest granularity - molecules, structure, and function. And we need to understand the spatial context of those. Spatial biology - a suite of various technologies - allows us to pinpoint which genes, proteins, metabolites, and other analytes are expressed where. Spatial biology is the next frontier in life sciences and beyond. Spatial biology reveals the precise cellular architecture of tissues and organs, how cells communicate and cooperate to execute tissue functions, as well as organ development itself. Furthermore, it allows the interrogation of cells in their native tissue context to disclose important processes in disease, including perturbations in cell-cell interactions. OMAPiX brings scale to the various spatial biology technologies that are mature to solve the biggest problems facing biology and medicine. OMAPiX works with its academic and pharma customers to undertake large-scale spatial biology projects - e.g. metascience, tissue atlasing, pharma studies, new model species. OMAPiX provides services from sample preparation to performing spatial biology experiments. OMAPiX does not stop there. We help our customers to go from the large spatial biology datasets to novel insights using advanced data analytics solutions. OMAPiX also endeavours to develop and scale some of the new spatial biology technologies that are on the anvil. Although based in Leuven (Belgium), OMAPiX caters to the global scientific audience. We look forward to working with you
- Website
-
http://www.omapix.com
Externer Link zu OMAPiX
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Langenfeld
- Art
- Privatunternehmen
- Gegründet
- 2022
- Spezialgebiete
- Spatial Biology, Big Data, Science, Medicine, Clinical Trials, Data analytics, Service und Technology
Orte
-
Primär
Raiffeisenstrasse
3
Langenfeld, 40764, DE
Beschäftigte von OMAPiX
Updates
-
OMAPiX hat dies direkt geteilt
OMAPiX is excited to work with BioSkryb Genomics to bring advanced single cell technologies to researchers. #singlecell #omics
We are excited to welcome OMAPiX to our Certified Service Provider (CSP) Program. “The launch of our Certified Service Provider Program is a key step in enabling more researchers to have access to our single-cell multiomic technology without establishing the protocols in their own laboratories. With OMAPiX now a member of our CSP program, researchers now have another trusted partner for their single-cell multiomics projects," said Don Trapolsi, AVP of Genomic Services at BioSkryb Genomics. For more details on our CSP Program and partners announced to date, visit https://lnkd.in/gbjCA2N3 For more details on OMAPiX's offerings, visit https://omapix.com/
-
OMAPiX is excited to work with BioSkryb Genomics to bring advanced single cell technologies to researchers. #singlecell #omics
We are excited to welcome OMAPiX to our Certified Service Provider (CSP) Program. “The launch of our Certified Service Provider Program is a key step in enabling more researchers to have access to our single-cell multiomic technology without establishing the protocols in their own laboratories. With OMAPiX now a member of our CSP program, researchers now have another trusted partner for their single-cell multiomics projects," said Don Trapolsi, AVP of Genomic Services at BioSkryb Genomics. For more details on our CSP Program and partners announced to date, visit https://lnkd.in/gbjCA2N3 For more details on OMAPiX's offerings, visit https://omapix.com/
-
As single-cell and spatial technologies emerge and mature, it is quite important for the users to be able to navigate through technical, application, and commercial considerations. This “living review” shaped through a community effort aims to provide continual updates as technological platforms and trends emerge. A big thanks to Adam Cribbs, Jake P. Taylor-King, Joachim De Jonghe for putting this team together. OMAPiX is excited to be a part of this effort and look forward to bring these exciting new technologies to key application areas. https://lnkd.in/dxFVtqF3 #spatial #singlecell #drugdiscovery #research
Great to see our scTrends review of commercial single-cell and spatial solutions out in Cell Genomics today, massive thank you to Jake P. Taylor-King Adam Cribbs James Opzoomer, Amaia, Benedikt and everyone else from the consortium for turning this into such an insightful piece, link: https://lnkd.in/g-a_UnP7
-
OMAPiX was honored this week to receive the techfrederick 2024 Techie award for Most Promising Start Up! We are so excited to be a part of the wonderful and welcoming Frederick tech community!
-
Unlock Novel Insights with MultiomicsFirst & OMAPiX At the forefront of discovery, multiomics analysis provides novel insights that drive meaningful data from the very beginning of your research process. Spatial Proteomics is the method of the year 2024! By leveraging Spatial Proteomics, we can enhance our understanding of target protein, offering unparalleled perspectives on biological processes at a fundamental clinical level. Spatial approaches are revolutionizing how we study proteins and their localization within cells. This breakthrough deepens our understanding of disease mechanisms and accelerates the identification of biomarkers and cellular profiles. With these insights, we can advance the development of new targeted therapies to address unmet clinical needs. OMAPiX is here to collaborate with you. Let's strategize the right solutions to ensure your program gets the comprehensive data it needs to push the boundaries of scientific discovery. #SpatialProteomics #Multiomics #BiomarkerDiscovery #TargetedTherapies #ClinicalResearch #Innovation #OMAPiX #ProteinLocalization #PrecisionMedicine
-
Congratulations and thank you, Kevin Matthew Byrd, DDS, PhD and team for your exceptional collaboration! The OMAPiX team is truly thrilled to be part of this groundbreaking initiative to support the development of the first integrated atlas of human adult oral and craniofacial tissues. This project offers a foundational framework for comprehensively exploring mucosal immunity and will be instrumental in guiding precision medicine approaches. The in-depth analysis and data generated represent a significant step forward in understanding the cellular, molecular, and spatial architecture of the oral cavity. We look forward to continuing our partnership! #Vizgen #spatial #biology
This project has been a dream come true. We are proud to present the first comprehensive atlas of the adult oral cavity, created using cutting-edge single-cell and spatial multiomic technologies, “The Immunoregulatory Architecture of the Adult Oral Cavity.” This foundational work provides an in-depth exploration of healthy mucosal and glandular tissues, offering key insights into structural immunity, its role in tissue homeostasis, and its potential as a therapeutic target in disease. Link: https://lnkd.in/etpRka-u Key takeaways: 1. Integrated analysis of >250,000 single cells from 70 healthy human oral tissue samples, spanning 13 niches, including salivary glands, mucosae, and pulp. 2. Spatial proteomics (CODEX/Phenocycler2.0) and transcriptomics (MERSCOPE) atlases, comprised of >2 million cells and through integrated, deep learning analysis, identifying 8 Tissue Cellular Neighborhoods (TCNs) and 17 Multicellular Interaction Modules (like neighborhoods for cell-cell communication; MCIMs) in gland and mucosae 3. We introduce AstroSuite, our advanced AI-assisted bioinformatics toolkit. This suite has transformed workflows with tools like TACIT, Constellation, and STARComm, enabling scalable spatial analysis, interactive visualization, and spatial receptor-ligand exploration. This atlas is part of the Human Cell Atlas initiative led by the Oral & Craniofacial Bionetwork and paving the way for next versions focusing on disease states like chronic inflammation and cancer. Future plans also include integrating findings into a comprehensive pan-airway spatial multiomics. We believe this is just the beginning of a transformative journey in oral and systemic health research. This would not have been possible without generous time, talent, and effort of lead authors Bruno Matuck, Khoa Huynh, and Diana Pereira and senior authors Ines Sequeira, Jinze Liu (Virginia Commonwealth University and Queen Mary University of London). More than that leadership team, however, was an incredible team of scientists XiuYu Zhang, Meik Kunz, Quinn Easter, Alexandre Fernandes, Alex Predeus, Paola Perez Riveros Ph.D., Adam Kimple, Sarah Pringle, Blake M. Warner, DDS, PhD, MPH, DABOMP, and many others across American Dental Association, OMAPiX, University of North Carolina at Chapel Hill, @Mildred-Scheel Early Career Centre for Cancer Research, The National Institutes of Health, University of Pennsylvania, University of Groningen. As always, we are grateful to Sarah Teichmann FMedSci FRS for her support, creativity, and guidance. Finally, collaborations with 10x Genomics, Vizgen, Akoya Biosciences, Inc. has made this possible; we remakn grateful for the trust and opportunity. Join us in celebrating this milestone, and stay tuned for updates as we expand this into diseased tissue contexts and therapeutic applications. #OralBiology #SpatialBiology #HumanCellAtlas #AstroSuite #PrecisionMedicine #CellCommunication
-
Unlocking the Power of Spatial Multiomics with SpatialScore https://lnkd.in/dKCiY3W6 Spatially resolved biomarkers are emerging as game changers. The concept of SpatialScore highlights how the spatial organization of cells within the tumor microenvironment can predict treatment response. This new class of pattern biomarkers doesn't just focus on gene expression but also on the complex spatial distribution and cells within tissues. Mapping these intricate spatial patterns can lead to developing low-plex panels for patient selection. As we continue to decode the complexity of the tumor microenvironment, spatial multiomics promises to refine our understanding and improve treatment outcomes. #SpatialScore #Biomarkers #PrecisionMedicine #PersonalizedHealthcare #CellularInteractions #CancerResearch #Immunotherapy #SpatialMultiomics